UBE2T and hepatocellular carcinoma: In addition, TCGA data analysis of 442 HCC patients showed that patients with high UBE2T expression (above the median level) had poorer overall survival (p = 0.0016, log-rank test) and disease-free survival (p = 0.0013, log-rank test) than patients with low UBE2T expression (Fig. 2c).